Literature DB >> 16432461

Anthropometric measures and risk of cutaneous malignant melanoma: a case-control study from Italy.

Silvano Gallus1, Luigi Naldi, Leigh Martin, Michele Martinelli, Carlo La Vecchia.   

Abstract

Several studies have investigated the effect of various anthropometric factors on the risk of cutaneous malignant melanoma (CMM). As the results are controversial, we analysed this issue in a case-control study conducted in Italy. The roles of several body size measures were investigated in a hospital-based case-control study of CMM conducted in Italy. The cases were 542 patients with CMM and the controls were 538 subjects admitted to the same hospitals as the cases for non-dermatological and non-neoplastic diseases. The odds ratios for the highest versus the lowest quartile were 2.06 [95% confidence interval (CI), 1.39-3.05] for weight, 1.16 (95% CI, 0.80-1.68) for height, 1.90 (95% CI, 1.28-2.80) for the body mass index (BMI) and 1.87 (95% CI, 1.28-2.72) for the body surface area (BSA). When allowing for BMI and BSA in the same model, the odds ratios were 1.55 (95% CI, 0.92-2.62) for BMI and 1.41 (95% CI, 0.85-2.33) for BSA. The present findings confirm that obesity increases the risk of CMM. BSA is also related to the risk of CMM. In terms of the population attributable risk, overweight and obesity would account for 31% of the cases of CMM in this Italian population, indicating the scope of prevention.

Entities:  

Mesh:

Year:  2006        PMID: 16432461     DOI: 10.1097/01.cmr.0000194429.77643.76

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  18 in total

1.  Voluntary exercise together with oral caffeine markedly stimulates UVB light-induced apoptosis and decreases tissue fat in SKH-1 mice.

Authors:  Yao-Ping Lu; Bonnie Nolan; You-Rong Lou; Qing-Yun Peng; George C Wagner; Allan H Conney
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-30       Impact factor: 11.205

2.  Association Between Melanoma Risk and Height: A Narrative Review.

Authors:  Gino A Vena; Nicoletta Cassano; Stefano Caccavale; Giuseppe Argenziano
Journal:  Dermatol Pract Concept       Date:  2019-04-30

3.  Adipocyte extracellular vesicles carry enzymes and fatty acids that stimulate mitochondrial metabolism and remodeling in tumor cells.

Authors:  Emily Clement; Ikrame Lazar; Camille Attané; Lorry Carrié; Stéphanie Dauvillier; Manuelle Ducoux-Petit; David Esteve; Thomas Menneteau; Mohamed Moutahir; Sophie Le Gonidec; Stéphane Dalle; Philippe Valet; Odile Burlet-Schiltz; Catherine Muller; Laurence Nieto
Journal:  EMBO J       Date:  2020-01-10       Impact factor: 11.598

Review 4.  Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer.

Authors:  K Karimi; T H Lindgren; C A Koch; Robert T Brodell
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

5.  Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study.

Authors:  Gillian K Reeves; Kirstin Pirie; Valerie Beral; Jane Green; Elizabeth Spencer; Diana Bull
Journal:  BMJ       Date:  2007-11-06

6.  Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma.

Authors:  Julia A Newton-Bishop; Samantha Beswick; Juliette Randerson-Moor; Yu-Mei Chang; Paul Affleck; Faye Elliott; May Chan; Susan Leake; Birute Karpavicius; Sue Haynes; Kairen Kukalizch; Linda Whitaker; Sharon Jackson; Edwina Gerry; Clarissa Nolan; Chandra Bertram; Jerry Marsden; David E Elder; Jennifer H Barrett; D Timothy Bishop
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544

7.  Cutaneous melanoma and obesity in the Agricultural Health Study.

Authors:  Leslie K Dennis; John B Lowe; Charles F Lynch; Michael C R Alavanja
Journal:  Ann Epidemiol       Date:  2008-03       Impact factor: 3.797

8.  Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data.

Authors:  Juliette A Randerson-Moor; John C Taylor; Faye Elliott; Yu-Mei Chang; Samantha Beswick; Kairen Kukalizch; Paul Affleck; Susan Leake; Sue Haynes; Birute Karpavicius; Jerry Marsden; Edwina Gerry; Linda Bale; Chandra Bertram; Helen Field; Julian H Barth; Isabel Dos Santos Silva; Anthony Swerdlow; Peter A Kanetsky; Jennifer H Barrett; D Timothy Bishop; Julia A Newton Bishop
Journal:  Eur J Cancer       Date:  2009-07-15       Impact factor: 9.162

9.  Role of BMI and hormone therapy in melanoma risk: a case-control study.

Authors:  Vincenzo De Giorgi; Alessia Gori; Imma Savarese; Antonietta D'Errico; Federica Scarfì; Federica Papi; Vincenza Maio; Piero Covarelli; Daniela Massi; Sara Gandini
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-13       Impact factor: 4.553

10.  Height, nevus count, and risk of cutaneous malignant melanoma: Results from 2 large cohorts of US women.

Authors:  Xin Li; Peter Kraft; Immaculata De Vivo; Edward Giovannucci; Liming Liang; Hongmei Nan
Journal:  J Am Acad Dermatol       Date:  2020-05-04       Impact factor: 15.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.